GlaxoSmithKline Senior Customer Service Manager Salaries in Wilmington, DE
The average GlaxoSmithKline Senior Customer Service Manager in Wilmington, DE earns an estimated $101,760 annually, which includes an estimated base salary of $87,385 with a $14,375 bonus. GlaxoSmithKline's Senior Customer Service Manager compensation is $31,465 more than the US average for a Senior Customer Service Manager. Senior Customer Service Manager salaries at GlaxoSmithKline in Wilmington, DE can range from $64,800 - $142,000.
In Wilmington, DE, The Customer Support Department at GlaxoSmithKline earns $10,048 more on average than the Operations Department.
Last updated 2 years ago.
- $87,385
- avg. base
- $14,375
- avg. bonus
Senior Customer Service Manager Salaries at GlaxoSmithKline
In Wilmington, DE, Senior Customer Service Managers earn $6,288 more than Customer Service Managers.
Compensation at GlaxoSmithKline by Department
In Wilmington, DE, The Customer Support Department averages $10,048 more than the Operations Department, and $859 less than the Legal Department
Senior Customer Service Manager Compensation by Gender (All Companies)
The average female Senior Customer Service Manager at companies similar size to GlaxoSmithKline reported making $64,747, while the average male Senior Customer Service Manager at similar sized companies reported making $93,274.
Senior Customer Service Manager Compensation by Ethnicity (All Companies)
The average Hispanic or Latino Senior Customer Service Manager at companies similar size to GlaxoSmithKline reported making $91,726, while the average Native American Senior Customer Service Manager at similar sized companies reported making $59,013.
How Senior Customer Service Managers at GlaxoSmithKline Rate Their Compensation
The majority of Senior Customer Service Managers at GlaxoSmithKline believe they're compensated fairly. 100% of Senior Customer Service Managers at GlaxoSmithKline say they receive annual bonuses, and the majority (54%) are satisfied with their benefits. See more compensation ratings at GlaxoSmithKline
